InvestorsHub Logo
Followers 0
Posts 1442
Boards Moderated 0
Alias Born 10/04/2017

Re: Door2Door post# 5480

Monday, 12/18/2017 5:48:48 PM

Monday, December 18, 2017 5:48:48 PM

Post# of 12427
OK Google it and got this " EndoPAT is an Innovative, safe and non-invasive diagnostic device for Functional Vascular Health Assessment for both large and small arteries. It is the only FDA cleared non-invasive test to evaluate the level of Endothelial Function." So basically the only direct FDA cleared competitor to LXGTF.